Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab
Public ClinicalTrials.gov record NCT05206357. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single Arm, Open-Label, Phase 1b Trial of Epcoritamab in Pediatric Patients With Relapsed/Refractory Aggressive Mature B-cell Neoplasms
Study identification
- NCT ID
- NCT05206357
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Genmab
- Industry
- Enrollment
- 17 participants
Conditions and interventions
Conditions
Interventions
- Epcoritamab Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Year to 25 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 3, 2022
- Primary completion
- Oct 31, 2028
- Completion
- Oct 31, 2028
- Last update posted
- Apr 7, 2025
2022 – 2028
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lucile Packard Children's Hospital /ID# 240854 | Palo Alto | California | 94304 | — |
| Nicklaus Children's Hospital /ID# 241174 | Miami | Florida | 33155-3009 | — |
| New York Medical College /ID# 239208 | Valhalla | New York | 10595 | — |
| Levine Children's Hospital /ID# 242765 | Charlotte | North Carolina | 28203 | — |
| Cincinnati Childrens Hospital Medical Center /ID# 239823 | Cincinnati | Ohio | 45229 | — |
| Children's Hospital of Philadelphia - Main /ID# 239294 | Philadelphia | Pennsylvania | 19104-4319 | — |
| St Jude Children's Research Hospital /ID# 239184 | Memphis | Tennessee | 38105 | — |
| University of Texas Southwestern Medical Center /ID# 240892 | Dallas | Texas | 75390-7208 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05206357, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2025 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05206357 live on ClinicalTrials.gov.